IL6 and cervical cancer: Additionally, the activation of the JAK/STAT3 pathway driven by IL‐6 was not identical to the previous prediction that strong STAT3 activation is representative in cervical high‐grade lesions and then withdraw in cervical cancer within tumor nests.3, 25